Medical overuse of therapies and diagnostics in rheumatology

Clin Rheumatol. 2021 May;40(5):2087-2094. doi: 10.1007/s10067-021-05638-2. Epub 2021 Feb 10.

Abstract

Medical overuse leads to a burden on healthcare costs and potentially is harmful to patients. We wanted to address medical overuse in musculoskeletal disease and rheumatology. We performed a systemic literature review from PubMed and Embase to study medical overuse. On the initial screen, 1499 studies were identified, 839 of them were related to medical overuse. Out of these, 52 were related to overuse in musculoskeletal diseases. Finally, 20 articles were chosen for this systemic review that reported overuse in rheumatology. The article identifies issues with overtesting, including the use of dual-energy X-ray absorptiometry to screen for osteoporosis in women younger than 65 years old and the use of magnetic resonance imaging to evaluate for osteoarthritis. Studies related to overtreatment reported over-prescription of vitamin D supplements resulting in vitamin D toxicity and increased risk of inappropriate prescriptions in patients with osteoarthritis and rheumatoid arthritis. Overtreating osteoporosis was reported after industry-sponsored education. Articles describing methods to reduce overuse included a study showing the reduction of unnecessary dual-energy X-ray absorptiometry scans after the introduction of the Choosing Wisely Campaign. Our findings suggest that there is some evidence that overtesting and overtreatment may be present in the field of rheumatology. This review aims to highlight this and help rheumatologists to be aware of overuse practices and provide appropriate evidence-based healthcare.

Keywords: Osteoarthritis; Overtesting; Overtreatment; Rheumatoid arthritis.

Publication types

  • Systematic Review

MeSH terms

  • Absorptiometry, Photon
  • Aged
  • Delivery of Health Care
  • Female
  • Humans
  • Medical Overuse*
  • Osteoporosis* / therapy
  • Rheumatic Diseases / therapy*
  • Rheumatology